Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

On the Mechanism of Release of Norepinephrine from Sympathetic Nerves Induced by Depolarizing Agents and Sympathomimetic Drugs

NGUYEN B. THOA, G. FREDERICK WOOTEN, JULIUS AXELROD and IRWIN J. KOPIN
Molecular Pharmacology January 1975, 11 (1) 10-18;
NGUYEN B. THOA
Laboratory of Clinical Science, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland 20014
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G. FREDERICK WOOTEN
Laboratory of Clinical Science, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland 20014
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JULIUS AXELROD
Laboratory of Clinical Science, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland 20014
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
IRWIN J. KOPIN
Laboratory of Clinical Science, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland 20014
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Depolarization of isolated guinea pig vasa deferentia in vitro by either hypertonic KCl or veratridine resulted in a dose-dependent, proportional release of norepinephrine and dopamine β-hydroxylase. The ratio of norepinephrine to dopamine β-hydroxylase activity released by depolarizing agents was similar to that obtained by electrical stimulation of the hypogastric nerve. Thus exocytosis from sympathetic nerve terminals may be elicited by depolarizing drugs as well as by electrical stimulation. Incubation of vasa deferentia in vitro in the presence of reserpine or the sympathomimetic amines tyramine, d-amphetamine, or metaraminol resulted in the dose-dependent release of norepinephrine but not of dopamine β-hydroxylase. When calcium was omitted from the incubation medium, exocytotic release of norepinephrine and dopamine β-hydroxylase induced by depolarizing agents was blocked whereas norepinephrine release induced by sympathomimetic agents was not affected. Tetrodotoxin blocked veratridine but not tyramine-induced release. Colchicine, but not hexamethonium or atropine, blocked exocytotic release. None of these drugs affected tyramine-induced release of norepinephrine. In vasa deferentia from untreated animals, the ratio of supernatant (S2) to particulate (P2) norepinephrine concentration after centrifugation at 100,000 x g for 1 hr was 0.7. In animals treated with reserpine and a monoamine oxidase inhibitor this ratio increased to 1.3, suggesting a release of norepinephrine from vesicular into intraneuronal cytoplasmic stores. The release of norepinephrine by tyramine was enhanced in vasa deferentia from reserpine- and monoamine oxidase inhibitor-treated animals and resulted in a fall in the norepinephrine content of the S2 fraction. This suggests that tyramine may act by displacing norepinephrine from cytoplasmic stores into the synaptic space. After treatment of guinea pigs with reserpine alone or in combination with a monoamine oxidase inhibitor, electrical stimulation of the hypogastric nerve to the guinea pig vas deferens resulted in release of dopamine β-hydroxylase but not of norepinephrine. This suggests that release by exocytosis may occur in the presence of a depleted amine store and that the norepinephrine released by exocytosis is derived predominantly from vesicular reserpine-sensitive stores.

ACKNOWLEDGMENT We thank Mrs. P. Cover for her competent technical assistance with the experiments.

  • Copyright ©, 1975, by Academic Press, Inc.

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology
Vol. 11, Issue 1
1 Jan 1975
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
On the Mechanism of Release of Norepinephrine from Sympathetic Nerves Induced by Depolarizing Agents and Sympathomimetic Drugs
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

On the Mechanism of Release of Norepinephrine from Sympathetic Nerves Induced by Depolarizing Agents and Sympathomimetic Drugs

NGUYEN B. THOA, G. FREDERICK WOOTEN, JULIUS AXELROD and IRWIN J. KOPIN
Molecular Pharmacology January 1, 1975, 11 (1) 10-18;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

On the Mechanism of Release of Norepinephrine from Sympathetic Nerves Induced by Depolarizing Agents and Sympathomimetic Drugs

NGUYEN B. THOA, G. FREDERICK WOOTEN, JULIUS AXELROD and IRWIN J. KOPIN
Molecular Pharmacology January 1, 1975, 11 (1) 10-18;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Analgesic Effects and Mechanisms of Licochalcones
  • Induced Fit Ligand Binding to CYP3A4
  • Englerin A Inhibits T-Type Channels
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics